“The Dysregulation of Mir-21 and Mir-143 As a Clinical Marker for Cancer Stem Cells in Tissue Samples of Iraqi Male Patients With Gastrointestinal Sarcoma”. Journal of Pharmaceutical Negative Results, vol. 13, no. 3, Sept. 2022, pp. 20-25, https://doi.org/10.47750/pnr.2022.13.03.004.